Olema Pharmaceuticals Inc

NASDAQ:OLMA   3:59:52 PM EDT
2.25
-0.05 (-2.17%)
Earnings Announcements

Olema Oncology Reports Q1 2022 Financial Results

Published: 05/09/2022 20:56 GMT
Olema Pharmaceuticals Inc (OLMA) - Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Qtrly Loss per Share $0.58.
Q1 Earnings per Share View $-0.57 -- Refinitiv Ibes Data (analyst estimates).
Anticipates That Cash Balance Will Be Sufficient to Fund Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.65

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.74

More details on our Analysts Page.